PATENT CLAIM ANALYSIS

Application Number: 15766560
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["544", "001000"]

Abstract:
The present invention provides a compound of the formula (1): wherein X, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , Y 1 , Y 2 , L, and m are as defined in the description, and a pharmaceutically acceptable salt thereof, which are useful as a vaccine adjuvant.

Claim (Index 22):
The method of  claim 16  wherein the compound activates one or both of TLR 7 and TLR 8.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 91.0
- Lexical Diversity: 1.65
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15763982', '15356311', '13416061', '10110381', '15507888']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.762096074020884
- 35 USC 102 Novelty (BERT): 0.547800552958301
- Combined Prediction Score: 0.7406665219146257
- Mean Citation Score: 307.9729240000001
- Max Citation Score: 405.57785
- Similarity Product: 271.0189712866604

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test